In the perioperative setting, temporary interruption of direct oral anticoagulants (DOACs) is recommended. However, the safety of these recommendations is based on non-urological surgical experiences. Our objective was to verify the safety of these recommendations in patients undergoing radical prostatectomy (RP).
INTRODUCTION AND OBJECTIVES:
In the perioperative setting, temporary interruption of direct oral anticoagulants (DOACs) is recommended. However, the safety of these recommendations is based on non-urological surgical experiences. Our objective was to verify the safety of these recommendations in patients undergoing radical prostatectomy (RP).
METHODS: Patients regularly receiving a DOAC and scheduled for RP at our institution were prospectively assessed. DOAC intake was usually stopped 48 hours before surgery without any preoperative bridging therapy. Postoperatively, patients received risk-adapted low-molecular-weight heparin (LMWH). On the third day after unremarkable RP, DOAC intake was restarted and administration of LMWH stopped. We assessed perioperative outcomes and 30-day morbidity.
RESULTS: Thirty-two consecutive patients receiving DOAC underwent RP at our institution between 12/2017 and 07/2018. Time of surgery (median, 177 minutes) and intraoperative blood loss (median, 500 mL) were unremarkable. DOACs were restarted on the third postoperative day in 30 patients (94%). No patient had a significant hemoglobin level reduction after DOAC restart. Overall, 28% of patients experienced complications within 30-days after surgery. Most of which were minor (Clavien 2 or smaller), three patients (9%), however, had Clavien 3 or higher complications.
CONCLUSIONS: Our report is the first to prospectively assess current guideline recommendations regarding DOAC restarting after major urological surgery. RP can safely be performed, if DOACs are correctly paused before surgery. Moreover, in case of an uneventful postoperative clinical course, DOACs can be safely restarted on the third postoperative day. A 9% Clavien 3 or higher 30-day morbidity warrants attention and should be further explored in future studies.
Source of Funding: none

MP60-14 COMPARING DEEP LEARNING, MACHINE LEARNING, AND CONVENTIONAL REGRESSION AS PREDICTIVE MODELS OF TIME TO URINARY CONTINENCE AFTER ROBOT-ASSISTED RADICAL PROSTATECTOMY
Andrew Hung*, Jian Chen, Los Angeles, CA; Zequn Liu, Beijing, China, People's Republic of; Jessica Nguyen, Los Angeles, CA; Sanjay Purushotham, Baltimore, MD; Yan Liu, Los Angeles, CA INTRODUCTION AND OBJECTIVES: Urinary continence is an important outcome after a robot-assisted radical prostatectomy (RARP). Survival analysis (time-to-event analysis) models predicting time to urinary continence recovery have not yet been trained with validated and objective measures of surgeon performance, such as automated performance metrics (APMs). Our study provides three predictive models (conventional regression analysis, machine learning, and deep learning algorithms) with APMs and clinicopathological data (CPD) to predict time to urinary continence recovery after RARPs.
METHODS: APMs (instrument motion tracking and system events data) and CPD were collected for 161 RARPs. The RARP was broken down into 12 steps, and for each step, 41 developed and validated APMs were reported. The predictive models were trained with three data sets: 1) APMs only; 2) CPD (i.e. prostate volume, Gleason score, PSA, pathological stage) only; 3) APMs þ CPD. We utilized Cox Proportional Hazards (CPH), Random Survival Forests (RSF), and Deep learning Models based Survival analysis (DeepSurv) to compare conventional regression analysis, machine learning, and deep learning, respectively. Concordance Index (CI) and Mean Absolute Error (MAE) measured prediction performance. For the top-performing model, data inputs (APMs and CPD) were ranked based on importance for urinary continence (no pads or 1 safety pad) prediction.
RESULTS: Out of the 161 RARP patients, 100 had at least three months follow-up data. 79% of patients achieved urinary continence with a median time of 126 days (16-553 days). DeepSurv, constructed on APMs and CPD, achieved the greatest prediction performance, with a high CI (0.60) and low MAE (85.9). Trained on the same data set, the CPH model had a CI 0.54 and MAE 134.7, while the RSF model had CI 0.58 and MAE 101.2. For DeepSurv, as the superior survival analysis model, only APMs (no CPD) were ranked in the top 25 data inputs for urinary continence prediction. Furthermore, three of the five top-ranked features were APMs measuring right instrument articulation during the vescio-urethral anastomosis and prostatic apical dissection steps of the RARP.
CONCLUSIONS: When trained with APMs and CPD, deep learning algorithms (DeepSurv) proved to be the superior survival analysis model to predict time to urinary continence recovery after a RARP. This model showed that APMs have a greater influence on time to urinary continence prediction.
Source of Funding:
This study was funded in part by an Intuitive Surgical Clinical Grant; Intuitive Surgical provided the systems data recorder. Research reported in this publication was also supported in part by the National Institute Of Biomedical Imaging And Bioengineering of the National Institutes of Health under Award Number K23EB026493.
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INTRODUCTION AND OBJECTIVES: Cerenkov Luminescence Imaging (CLI) is a molecular imaging technique that detects light emitted by Positron Emission Tomography (PET) radiopharmaceuticals.
This first-in-men study evaluates 68 Ga-PSMA for intraoperative assessment of tumor margins at time of robot-assisted radical prostatectomy following preoperative PSMA-PET/CT. METHODS: 3-4 hours prior to surgery, PSMA-PET/CT was performed after intravenous injection of 68 Ga-PSMA with varying doses. Scan results were assessed by the specialists of nuclear medicine and urology. Radical prostatectomy was performed robotically and the prostate specimen was imaged with a CLI imager (Lightpoint Medical Ltd, UK) intraoperatively immediately after excision. Mean radiance (photons/s/cm 2 /sr) was measured as well as the agreement in margin distance on histopatholgy and CLI.
RESULTS: CLI was used in five patients after preoperative injection of 144 mBq 68 Ga-PSMA (mean, range 95-202). Intraprostatic lesions were detected by PSMA-PET/CT in 100%, positive lymph nodes could be seen in 3 of 5 patients. CLI was performed intraoperatively after a mean of 329 minutes after tracer injection. Mean background radiance of the prostate was 1441 photons/s/cm 2 /sr. Positive surgical margins were found in two patients based on histopathology (patient 1: pT3b, pN1, Gleason score 5þ3 [8, patient 2: pT3a, pN1, Gleason score 4þ5[9) . In these patients, elevated radiance levels were found in the tumor positive areas (mean radiance: 4254 photons/s/cm
